IRIS Accounts Production v23.4.0.336 11057944 director 1.12.22 30.11.23 30.11.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh110579442022-11-30110579442023-11-30110579442022-12-012023-11-30110579442021-11-30110579442021-12-012022-11-30110579442022-11-3011057944ns15:EnglandWales2022-12-012023-11-3011057944ns14:PoundSterling2022-12-012023-11-3011057944ns10:Director12022-12-012023-11-3011057944ns10:PrivateLimitedCompanyLtd2022-12-012023-11-3011057944ns10:SmallEntities2022-12-012023-11-3011057944ns10:AuditExempt-NoAccountantsReport2022-12-012023-11-3011057944ns10:SmallCompaniesRegimeForDirectorsReport2022-12-012023-11-3011057944ns10:SmallCompaniesRegimeForAccounts2022-12-012023-11-3011057944ns10:FullAccounts2022-12-012023-11-3011057944ns10:RegisteredOffice2022-12-012023-11-3011057944ns5:CurrentFinancialInstruments2023-11-3011057944ns5:CurrentFinancialInstruments2022-11-3011057944ns5:ShareCapital2023-11-3011057944ns5:ShareCapital2022-11-3011057944ns5:RetainedEarningsAccumulatedLosses2023-11-3011057944ns5:RetainedEarningsAccumulatedLosses2022-11-30
REGISTERED NUMBER: 11057944 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30TH NOVEMBER 2023

FOR

ZEPHAPHARM LTD

ZEPHAPHARM LTD (REGISTERED NUMBER: 11057944)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30TH NOVEMBER 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


ZEPHAPHARM LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 30TH NOVEMBER 2023







DIRECTOR: Mr J R Taylor





REGISTERED OFFICE: The Harley Building
77 New Cavendish Street
London
London
W1W 6XB





REGISTERED NUMBER: 11057944 (England and Wales)





ACCOUNTANTS: Richardson Jones
Chartered Accountants
Mercury House
19-21 Chapel Street
Marlow
Buckinghamshire
SL7 3HN

ZEPHAPHARM LTD (REGISTERED NUMBER: 11057944)

BALANCE SHEET
30TH NOVEMBER 2023

30.11.23 30.11.22
Notes £ £
CURRENT ASSETS
Cash at bank 860 860

CREDITORS
Amounts falling due within one year 4 2,296 2,008
NET CURRENT LIABILITIES (1,436 ) (1,148 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(1,436

)

(1,148

)

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings (1,536 ) (1,248 )
(1,436 ) (1,148 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th November 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th November 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 5th April 2024 and were signed by:





Mr J R Taylor - Director


ZEPHAPHARM LTD (REGISTERED NUMBER: 11057944)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30TH NOVEMBER 2023

1. STATUTORY INFORMATION

Zephapharm Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

4. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.23 30.11.22
£ £
Other creditors 2,296 2,008

5. RELATED PARTY DISCLOSURES

The company has a loan outstanding of £1,000 from a company of which the director is also a director. This company has also paid for fees on behalf of Zephapharm Ltd totalling £288 during the year to 30 November 2023. The total amount outstanding as at 30 November 2023 was £2,056 (2022: £1,768). The interest rate applied to the loan of £1,000 is 0.5%.